Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Nobuo Arai"'
Autor:
Atsuo Suzuki, Nobuaki Suzuki, Takeshi Kanematsu, Sho Shinohara, Hiroshi Kurono, Nobuo Arai, Shuichi Okamoto, Naruko Suzuki, Shogo Tamura, Ryosuke Kikuchi, Akira Katsumi, Tetsuhito Kojima, Tadashi Matsushita
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract Plasma fibrinogen is commonly examined by Clauss fibrinogen assay, which cannot distinguish between quantitative and qualitative fibrinogen anomalies. However, our previously reported Clauss fibrinogen assay utilizing clot waveform analysis
Externí odkaz:
https://doaj.org/article/bab0b468fae849ba97a1aa9089dfc33a
Autor:
Masahiro Kusumoto, Yukino Tamamura-Andoh, Masato Akiba, Taketoshi Iwata, Hideaki Niwa, Eri Uchida-Fujii, Nobuo Arai, Ayako Watanabe-Yanai, Yuta Kinoshita
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 27, Iss, Pp 225-227 (2021)
Objectives Extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae have become a cause for great concern. Although some studies have reported the prevalence of ESBL-producing bacteria and ESBL-encoding genes in horses worldwide, the geneti
Autor:
Nobuo Arai, Mitsutoshi Sugano, Sho Shinohara, Fumiaki Hayashi, Tomu Kamijo, Takeshi Uehara, Takayuki Honda, Shinpei Arai, Nobuo Okumura
Publikováno v:
International journal of laboratory hematology. 43(2):281-289
Article
International journal of laboratory hematology. 43(2): 281-289(2021)
International journal of laboratory hematology. 43(2): 281-289(2021)
Autor:
Yoshino Mizuno, Keisuke Sato, Ayako Watanabe-Yanai, Yukino Tamamura-Andoh, Nobuo Arai, Masahiro Kusumoto, Nobuyuki Tanaka, Masato Akiba
Publikováno v:
Journal of Veterinary Medical Science. 83:754-758
We examined the antimicrobial susceptibility of 848 Escherichia coli isolates from 237 feces samples of wild sika deer (Cervus nippon) captured between 2016 and 2019 in 39 of the 47 prefectures of Japan. Five of the 237 wild sika deer (2.1%) carried
Autor:
Nobuo Arai, Tsuyoshi Sekizuka, Yukino Tamamura-Andoh, Lisa Barco, Atsushi Hinenoya, Shinji Yamasaki, Taketoshi Iwata, Ayako Watanabe-Yanai, Makoto Kuroda, Masato Akiba, Masahiro Kusumoto
Publikováno v:
Frontiers in Microbiology, Vol 12 (2021)
Frontiers in Microbiology
Frontiers in Microbiology
Salmonella enterica subsp. enterica serovar Typhimurium sequence type 34 (ST34) and its monophasic variant (Salmonella 4,[5],12:i:-) are among the most frequently isolated clones from both humans and animals worldwide. Our previous study demonstrated
Autor:
Mitsutoshi Sugano, Takeshi Suzuki, Sho Shinohara, Takahiro Kaido, Tomu Kamijo, Nobuo Okumura, Masahiro Yoda, Shinpei Arai, Nobuo Arai, Takeshi Uehara
Publikováno v:
Clinica chimica acta; international journal of clinical chemistry. 521
Article
Clinica chimica acta. 521: 170-176(2021)
Clinica chimica acta. 521: 170-176(2021)
Publikováno v:
British Journal of Haematology. 187:518-529
Simultaneous evaluation of coagulation and fibrinolysis facilitates an overall understanding of normal and pathological haemostasis. We established an assay for assessing clot formation and fibrinolysis simultaneously using clot waveform analysis by
Autor:
Sho Shinohara, Ryosuke Kikuchi, Nobuo Arai, Takeshi Kanematsu, Nobuaki Suzuki, Atsuo Suzuki, Tadashi Matsushita
Publikováno v:
International Journal of Laboratory Hematology. 41:664-670
Introduction Chromogenic substrate assay (CSA) reagents Revohem™ FVIII and Revohem™ FIX are now available as in vitro diagnostic reagents for autoanalysers in Japan. In this study, we evaluated the performance of these reagents in the CS-5100 aut
Autor:
Shinji Yamasaki, Lisa Barco, Taketoshi Iwata, Masato Akiba, Yukino Tamamura-Andoh, Atsushi Hinenoya, Tsuyoshi Sekizuka, Ayako Watanabe-Yanai, Makoto Kuroda, Masahiro Kusumoto, Nobuo Arai
Salmonella Typhimurium and its monophasic variant (Salmonella 4,[5],12:i:-) are classified into nine clades. Clade 9 is composed of ST34 strains, including the Salmonella 4,[5],12:i:-European clone, which has rapidly disseminated in humans and animal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::26330edb542728f6bcd67b43b8627d1c
https://doi.org/10.1101/2020.10.14.338830
https://doi.org/10.1101/2020.10.14.338830
Autor:
Tetsuhiro Soeda, Tomoko Matsumoto, Michinori Hirata, Keiji Nogami, Naruto Shimonishi, Fumie Nakazawa, Nobuo Arai, Kenichi Ogiwara, Midori Shima
Publikováno v:
Haemophilia. 26
Introduction Emicizumab is an antifactor (F)IXa/FX bispecific antibody, mimicking FVIIIa cofactor function. Emi prophylaxis effectively reduces bleeding events in patients with haemophilia A. The physical properties of emicizumab-induced fibrin clots